About Jubilant Pharma
Jubilant Pharma is a Healthcare company based in Noida (India) founded in 1978. Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Its Indian entity Vanthys Pharmaceutical Development Private Limited reported revenue of ₹29.5 Lakh. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
Founded in 1978 and headquartered in Noida, India, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients are produced for other firms, alongside generic and specialty drugs, including allergy therapies. Contract manufacturing is provided for parenteral products, ophthalmics, ointments, creams, and gels. Radiopharmaceuticals for nuclear medicine are specialized in, supported by a global pharmacy network. Finished dosage forms are supplied across various therapeutic areas.
- Headquarters Noida, India
- SectorsHealthcare
- Website jubilantpharma.com
- Social LinkedIn
- Legal Name Vanthys Pharmaceutical Development Private Limited
- Date of Incorporation 11 May, 2009
- Jurisdiction Noida, Uttar Pradesh, India
- Annual Revenue₹29.5 Lakh
FY 2018 · 0% YoY
- Net Profit₹20.6 Lakh
FY 2018 · 70% margin
- EBITDA₹27.6 Lakh
FY 2018 · 94% margin
- Latest Funding Round$400M (USD), Debt – Conventional
Jul 2022
- Investors
Associated legal entities of Jubilant Pharma
Jubilant Pharma operates through Vanthys Pharmaceutical Development Private Limited (dissolved (liquidated)). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2018) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vanthys Pharmaceutical Development Private Limited CIN U73100UP2009PTC037333 | Dissolved (Liquidated) | 11 May 2009 | Noida, Uttar Pradesh | ₹0.3 Cr | 6 | View details |
Funding Insights of Jubilant Pharma
- Total Rounds 2
- Last Round Debt – Conventional — $400M
- First Round $200M
(Mar 2019)
- Investors Count 1
All 2 funding rounds of Jubilant Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $400M | Debt – Conventional | – | – | |
| Mar 2019 | $200M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Jubilant Pharma
Jubilant Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Standard Chartered.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate, investment, wealth, and retail banking services are provided globally. | 1953 | sc.com | London, United Kingdom |
Investor details for Jubilant Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vanthys Pharmaceutical Development Private Limited (Jubilant Pharma)
Vanthys Pharmaceutical Development Private Limited is the primary company behind Jubilant Pharma. The board of Vanthys Pharmaceutical Development Private Limited currently have 4 directors; the longest-serving is Shwetank Tiwari, appointed in 2018. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shwetank Tiwari DIN 02413671 | Company Secretary | 16 Jan 2018 | 8 yrs 9 mo | Vanthys Pharmaceutical Development Private Limited |
| Benny Thomas DIN 07241561 | Director | 28 Mar 2018 | 8 yrs 7 mo | Vanthys Pharmaceutical Development Private Limited |
| Shyamsundar Bang DIN 00011327 | Director | 28 Mar 2018 | 8 yrs 7 mo | Vanthys Pharmaceutical Development Private Limited |
| Saravanakumar Dhakshinamoorthy DIN 08448999 | Additional Director | 15 May 2019 | 7 yrs 5 mo | Vanthys Pharmaceutical Development Private Limited |
People of Jubilant Pharma
22 people are tracked at Jubilant Pharma (7 in leadership, 15 in team).
| Name | Role | Group |
|---|---|---|
Shyam S Bhartia | Managing Director | Leadership |
Chris Preti | Chief Executive Officer | Leadership |
Elizabeth Arnold | Associate Director, PMO | Leadership |
Mark Sassler | Business Director - Ophthalmic Business | Leadership |
Hajar Sbihi | Associate Director Technical Services | Leadership |
Ian Fuller | Senior Vice President Operations | Leadership |
Genevieve Thibeault | Associate Director Commercial | Leadership |
Sarah Breland | Business Excellence Manager | Team |
Virginie Meynard | Engineering Project Manager | Team |
Zied Damergi | Senior Project Manager | Team |
Ian Oldenburg | Project Engineer I | Team |
Clayton Fosberg | Project Engineer | Team |
Jack Berry | Sr Project Manager | Team |
Brad Wilson | Project Engineer III | Team |
Aaron Wahl | Operations Lead-filling | Team |
Joel Hedman | Plant Project Engineer | Team |
Lauren Orr | Technical Marketing Specialist | Team |
Michael Jack | Senior Manager, Technical Sales Operations | Team |
Nazihah Bakhtyar | Senior Manager Of Business Development | Team |
Kim Durgan | Manager, Bd/pmo | Team |
2 more people are available in the full profile.
Complete people profiles for Jubilant Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Jubilant Pharma
Figures of Vanthys Pharmaceutical Development Private Limited, the primary company behind Jubilant Pharma, for FY 2018. Revenue was ₹29.5 Lakh (0% year on year). Net profit was ₹20.6 Lakh (70% margin). EBITDA was ₹27.6 Lakh (94% margin). Revenue has grown at a compounded annual rate of +1% over three years.
- ₹29.5 LakhRevenue · FY 2018 · 0% YoY
- ₹20.6 LakhNet profit · 70% margin
- ₹27.6 LakhEBITDA · 94% margin
- ₹22.50 CrPaid-up capital
- +1%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Vanthys Pharmaceutical Development Private Limited are on its company page.
Detailed financial statements for Jubilant Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Jubilant Pharma
3 dated milestones of Jubilant Pharma across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Jubilant Pharma is founded.
- Funding First funding round of $200.0M.
- Funding Latest funding round, Debt – Conventional, of $400.0M.
Web traffic of Jubilant Pharma
The website of Jubilant Pharma (jubilantpharma.com) receives about 7K visits a month.
- Monthly visits7K
▲ 1.3% vs previous month
Websites whose visitors overlap most with Jubilant Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| savaglobal.com | 100% | 6K | #4,334,220 | View details | |
| bwhealthcareworld.com | 57% | #1,197,358 | View details | ||
| biocon.com | 52% | 82.3K | #297,196 | View details | |
| jubilantpharmova.com | 28% | 7K | #3,116,802 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Jubilant Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jubilant Pharma
Complete news archive for Jubilant Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jubilant Pharma
Jubilant Pharma was founded in 1978 and raised its 1st funding round 41 years after it was founded.
Jubilant Pharma is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
The primary company behind Jubilant Pharma, Vanthys Pharmaceutical Development Private Limited, reported revenue of ₹29.5 Lakh for FY 2018, down 0% year on year.
Founded in 1978 and headquartered in Noida, India, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients are produced for other firms, alongside generic and specialty drugs, including allergy therapies. Contract manufacturing is provided for parenteral products, ophthalmics, ointments, creams, and gels. Radiopharmaceuticals for nuclear medicine are specialized in, supported by a global pharmacy network. Finished dosage forms are supplied across various therapeutic areas.
Jubilant Pharma has 1 investor. Key investors include Standard Chartered.
Jubilant Pharma operates through Vanthys Pharmaceutical Development Private Limited.
The legal entities of Jubilant Pharma currently have 5 directors, including Nitin Garg, Benny Thomas, Saravanakumar Dhakshinamoorthy and others.